Role of Aloe Vera Versus Fluoride Toothpaste in Changing High to Low Salivary Bacterial Count

NCT ID: NCT03108313

Last Updated: 2017-07-31

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE2

Total Enrollment

58 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-03-03

Study Completion Date

2018-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Patient's salivary bacterial count will be evaluated , then the patient will bbe instructed to follow oral hygiene measures including the use of aloe vera toothpaste or fluoride toothpaste , the after 15 days and 30 days the patient's salivary bacterial count will be evaluated another time.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Variables of study:

Each patient will be instructed to follow oral hygiene measures including aloe vera or fluoride toothpaste

Outcomes:

Salivary bacterial count will be evaluated using Mitis salivarius agar plates before the use of the aloe vera toothpaste then after 15 days then after 30 days .

Participant timeline:

Enrolment Baseline assessment 15 days 30 days

(1st visit ) (2nd visit) (3rd visit )

II.6.Sample size calculation :

Based on previous study , the mean percent change reduction in bacterial count was 3+4 . using power 80 % and 5 % significance level , we will need to study 29 in each group to be able to reject the null hypothesis that the population means of the experimental and control groups are equal with probability (power) 0.8. The Type I probability associated with this test of this null hypothesis is 0.05.

Recruitment \& Recruitment Strategy:

Screening of patients that come to the conservative dentistry department seeking dental care will continue until the target population is achieved. The patients will be subjected to full examination and diagnosis using dental charts. Once the patients that are potentially eligible for this study are identified, they will be contacted by the research investigator who will explain the study and ascertains the patient's interest. Randomization and assignment of interventions:

Randomization will be done according to a check list including the number of participants divided into 2 groups according to interventions/Control assessment method

Allocation sequence generation:

The allocation sequence will be generated using (www.randomization.com).

Allocation concealment mechanism:

A checklist will be designed to identify each assessment method.

Implementation A participant will generate the random allocation sequence. The researcher will enroll the patients but an unbiased participant will assign the intervention/Control identification procedures to respective teeth.

Blinding:

The participants will be blinded to intervention/control assessment methods. Also, it will not be allowed amongst the examiners to exchange any information throughout the entire study period.

Data collection methods:

High caries index will be assessed 3 times , at base line , then 15 days and 30 days.

Funding:

The research will be self-funded by the researcher.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Caries, Dental

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Outcome Assessors
A participant will generate the random allocation sequence. The researcher will enroll the patients but an unbiased participant will assign the intervention/Control identification procedures .The participants will be blinded to intervention/control assessment methods. Also, it will not be allowed among the examiners to exchange any information throughout the entire study period.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

aloe vera toothpaste

aloe vera toothpaste isa will be administrated 2 times per day for 30 days and salivary bacterial count will be tested before the use of toothpaste the after 15 days and 30 days

Group Type EXPERIMENTAL

aloe vera toothpaste

Intervention Type DRUG

herbal toothpaste used to decrease salivary streptococcus bacterial count

fluoride toothpaste

fluoride toothpaste isa herbal toothpaste will be administrated 2 times per day for 30 days and salivary bacterial count will be tested before the use of toothpaste the after 15 days and 30 days

Group Type ACTIVE_COMPARATOR

fluoride toothpaste

Intervention Type DRUG

chemical toothpaste used to decrease salivary streptococcus bacterial count

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

aloe vera toothpaste

herbal toothpaste used to decrease salivary streptococcus bacterial count

Intervention Type DRUG

fluoride toothpaste

chemical toothpaste used to decrease salivary streptococcus bacterial count

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

aloe dent toothpaste aloe dent signal toothpaste

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients should have poor oral hygiene.
* Patients should have high bacterial count

Exclusion Criteria

* Patients with a compromised medical history.
* Severe or active periodontal disease .
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Cairo University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Neven Ahmed Ebrahim

principal investigator, resident at conservative department

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Amira Farid, PHD

Role: STUDY_DIRECTOR

professor at conservative department cairo university

Rasha Rafaat, PHD

Role: STUDY_CHAIR

lecturer at conservative department cairo university

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Neven Ahmed Ebrahim

Cairo, Heliopolis, Egypt

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Neven Ahmed Ebrahim, master

Role: CONTACT

Phone: 01153621944

Email: [email protected]

Neven Ahmed Ebrahim, master

Role: CONTACT

Phone: 01005475566

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Neven Ahmed Ebrahim, master

Role: primary

Neven Ahmed Ebrahim, master

Role: backup

References

Explore related publications, articles, or registry entries linked to this study.

Bhati N, Jaidka S, Somani R. Evaluation of antimicrobial efficacy of Aloe vera and Meswak containing dentifrices with fluoridated dentifrice: An in vivo study. J Int Soc Prev Community Dent. 2015 Sep-Oct;5(5):394-9. doi: 10.4103/2231-0762.165924.

Reference Type BACKGROUND
PMID: 26539392 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CEBC-CU-2017-30-16

Identifier Type: -

Identifier Source: org_study_id